← All Sponsors
SPONSOR

Shanghai Exuma Biotechnology Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Diffuse Large B-cell-lymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3BPMBLHGBL With MYC and BCL2 and/or BCL6 RearrangementsHGBL, Nos
NCT06830031 Phase 1
Recruiting

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

Diffuse Large B-cell-lymphoma
China View Trial →